title: Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.
abstract: BACKGROUND
  Podocyte injury is an early feature of diabetic nephropathy (DN). Recently, urinary exosomal Wilm's tumor-1 protein (WT1), shed by renal epithelial cells, has been proposed as a novel biomarker for podocyte injury. However, its usefulness as biomarker for early diabetic nephropathy has not been verified yet. We investigated urinary exosomal WT1 in type-1 diabetic patients to confirm its role as a non-invasive biomarker for predicting early renal function decline.
  
  
  METHODS
  The expression of WT1 protein in urinary exosomes from spot urine samples of type-1 diabetes mellitus patients (n = 48) and healthy controls (n = 25) were analyzed. Patients were divided based on their urinary albumin excretion, ACR (mg/g creatinine) into non- proteinuria group (ACR<30 mg/g, n = 30) and proteinuria group (ACR>30 mg/g, n = 18). Regression analysis was used to assess the association between urinary exosomal levels of WT1 with parameters for renal function. Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic performance of exosomal WT-1.
  
  
  RESULTS
  WT1 protein was detected in 33 out of 48 diabetic patients and in only 1 healthy control. The levels of urinary exosomal WT1 protein is significantly higher (p = 0.001) in patients with proteinuria than in those without proteinuria. In addition, all the patients with proteinuria but only half of the patients without proteinuria were positive for exosomal WT1. We found that the level of exosomal WT1 were associated with a significant increase in urine protein-to-creatinine ratio, albumin-to-creatinine ratio, and serum creatinine as well as a decline in eGFR. Furthermore, patients exhibiting WT1-positive urinary exosomes had decreased renal function compared to WT1-negative patients. ROC analysis shows that WT-1 effectively predict GFR<60 ml. min-1/1.73 m(2).
  
  
  CONCLUSIONS
  The predominant presence of WT1 protein in urinary exosomes of diabetic patients and increase in its expression level with decline in renal function suggest that it could be useful as early non-invasive marker for diabetic nephropathy.
authors.affiliation: Department of Molecular Medicine & Biotechnology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
authors.forename: Anuradha
authors.initials: A
authors.lastname: Kalani
authors.forename: Aradhana
authors.initials: A
authors.lastname: Mohan
authors.forename: Madan M
authors.initials: MM
authors.lastname: Godbole
authors.forename: Eesh
authors.initials: E
authors.lastname: Bhatia
authors.forename: Amit
authors.initials: A
authors.lastname: Gupta
authors.forename: Raj Kumar
authors.initials: RK
authors.lastname: Sharma
authors.forename: Swasti
authors.initials: S
authors.lastname: Tiwari
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology / Q000652:urine*; D055354:Exosomes / Q000378:metabolism*; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology; D006801:Humans; D008297:Male; D011507:Proteinuria / Q000150:complications* / Q000503:physiopathology / Q000652:urine*; D025721:WT1 Proteins / Q000652:urine*
chemical_list: D025721:WT1 Proteins
references.citation: Eur J Clin Invest. 1999 Oct;29(10):824-6
references.pmid: 10583423
references.citation: Kidney Int. 2010 Jan;77(1):57-64
references.pmid: 19847154
references.citation: Kidney Int. 2006 Apr;69(8):1471-6
references.pmid: 16501490
references.citation: Kidney Int. 2010 Apr;77(8):736-42
references.pmid: 20130532
references.citation: Ann Intern Med. 2006 Aug 15;145(4):247-54
references.pmid: 16908915
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1760-71
references.pmid: 16837576
references.citation: Diabetes. 2000 Sep;49(9):1399-408
references.pmid: 10969821
references.citation: Diabetes. 2006 Jan;55(1):225-33
references.pmid: 16380497
references.citation: J Am Soc Nephrol. 2009 Feb;20(2):363-79
references.pmid: 19056867
references.citation: Diabetes Res Clin Pract. 2010 Feb;87(2):167-75
references.pmid: 19969384
references.citation: Postgrad Med J. 2004 Nov;80(949):624-33
references.pmid: 15537844
references.citation: Indian J Nephrol. 2011 Oct;21(4):219-20
references.pmid: 22022078
references.citation: Diabetes. 2011 Sep;60(9):2354-69
references.pmid: 21752957
references.citation: Clin Sci (Lond). 2007 Jun;112(6):325-35
references.pmid: 17291194
references.citation: Pediatr Nephrol. 2012 Feb;27(2):317-20
references.pmid: 22076591
references.citation: Am J Physiol Renal Physiol. 2003 Jul;285(1):F40-8
references.pmid: 12631553
references.citation: Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:999-1004
references.pmid: 18806717
references.citation: Diabetes. 2005 Jun;54(6):1626-34
references.pmid: 15919782
references.citation: Kidney Int. 2008 Sep;74(5):613-21
references.pmid: 18509321
references.citation: J Am Soc Nephrol. 2005 Feb;16(2):408-16
references.pmid: 15625073
references.citation: PLoS One. 2011;6(5):e20431
references.pmid: 21655212
references.citation: QJM. 2009 Aug;102(8):523-38
references.pmid: 19553250
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73
references.pmid: 15326289
references.citation: Clin Exp Hypertens. 2009 Feb;31(1):49-63
references.pmid: 19172459